Michael J. Regan

733 total citations
22 papers, 490 citations indexed

About

Michael J. Regan is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Michael J. Regan has authored 22 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in Michael J. Regan's work include Respiratory Support and Mechanisms (4 papers), Phase-change materials and chalcogenides (3 papers) and Metallic Glasses and Amorphous Alloys (3 papers). Michael J. Regan is often cited by papers focused on Respiratory Support and Mechanisms (4 papers), Phase-change materials and chalcogenides (3 papers) and Metallic Glasses and Amorphous Alloys (3 papers). Michael J. Regan collaborates with scholars based in United States, Ireland and Australia. Michael J. Regan's co-authors include Edmond I. Eger, Edwin S. Munson, John W. Severinghaus, Bernard Brandstater, Lawrence J. Saidman, Arthur Bienenstock, B. M. Ocko, Jean-François Legrand, Olaf M. Magnussen and P. S. Pershan and has published in prestigious journals such as Nature, Physical review. B, Condensed matter and Anesthesiology.

In The Last Decade

Michael J. Regan

22 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Regan United States 12 100 99 75 58 51 22 490
J. R. Richards United Kingdom 12 97 1.0× 126 1.3× 12 0.2× 39 0.7× 8 0.2× 23 892
Sung Wook Park South Korea 19 115 1.1× 43 0.4× 187 2.5× 31 0.5× 22 0.4× 90 983
José M. Brum United States 21 46 0.5× 96 1.0× 47 0.6× 6 0.1× 40 0.8× 52 1.7k
Graham Smith United Kingdom 11 121 1.2× 103 1.0× 110 1.5× 73 1.3× 2 0.0× 23 662
E Kanal United States 10 31 0.3× 107 1.1× 9 0.1× 17 0.3× 67 1.3× 12 727
Amit Prabhakar United States 20 180 1.8× 79 0.8× 171 2.3× 29 0.5× 5 0.1× 66 1.3k
H. Saito Japan 15 120 1.2× 11 0.1× 149 2.0× 162 2.8× 4 0.1× 46 817
Francis J. Bonner United States 13 19 0.2× 83 0.8× 26 0.3× 11 0.2× 19 0.4× 28 689
Masaya Yasui Japan 14 21 0.2× 55 0.6× 69 0.9× 4 0.1× 20 0.4× 39 666
Jinghua Jiao China 14 38 0.4× 57 0.6× 106 1.4× 17 0.3× 17 0.3× 42 533

Countries citing papers authored by Michael J. Regan

Since Specialization
Citations

This map shows the geographic impact of Michael J. Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Regan more than expected).

Fields of papers citing papers by Michael J. Regan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Regan. The network helps show where Michael J. Regan may publish in the future.

Co-authorship network of co-authors of Michael J. Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Regan. A scholar is included among the top collaborators of Michael J. Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Regan. Michael J. Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNamara, Brian, et al.. (2020). Acute severe sensory ganglionopathy in systemic lupus erythematous. Neuromuscular Disorders. 30(8). 701–706. 3 indexed citations
2.
Ullah, Rahim, et al.. (2019). Coeliac disease presenting with chorea. Practical Neurology. 20(2). 144–147. 3 indexed citations
3.
Regan, Michael J., et al.. (2011). Cervical Spinal Cord Tumor Causing Complex Regional Pain Syndrome. Mayo Clinic Proceedings. 86(8). 713–713. 2 indexed citations
4.
Haroon, Muhammad & Michael J. Regan. (2010). Vitamin D deficiency: the time to ignore it has passed. International Journal of Rheumatic Diseases. 13(4). 318–323. 14 indexed citations
5.
Haroon, Muhammad, Ursula Bond, Niamh Quillinan, Mark J. Phelan, & Michael J. Regan. (2010). The prevalence of vitamin D deficiency in consecutive new patients seen over a 6-month period in general rheumatology clinics. Clinical Rheumatology. 30(6). 789–794. 22 indexed citations
6.
Bond, Ursula, et al.. (2009). The Preferences for Outpatient Clinic Appointment Reminders Among Rheumatology Patients. JCR Journal of Clinical Rheumatology. 15(5). 258–259. 6 indexed citations
7.
Phelan, Mark J., et al.. (2009). Inflammatory bowel disease, such as Ulcerative colitis, is a risk factor for recurrent thromboembolic events: a case report. Cases Journal. 2(1). 173–173. 2 indexed citations
8.
Phelan, Mark J., et al.. (2007). The use of etoricoxib to treat an idiopathic stabbing headache: a case report. Journal of Medical Case Reports. 1(1). 100–100. 3 indexed citations
9.
Regan, Michael J., Bradford J. Wood, Yu‐Hsiang Hsieh, et al.. (2002). Temporal arteritis and Chlamydia pneumoniae: Failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis & Rheumatism. 46(4). 1056–1060. 38 indexed citations
10.
Regan, Michael J., David B. Hellmann, & John H. Stone. (2001). TREATEMENT OF WEGENER'S GRANULOMATOSIS. Rheumatic Disease Clinics of North America. 27(4). 863–886. 11 indexed citations
11.
Regan, Michael J., et al.. (2001). Central nervous system vasculitis as a complication of refractory dermatomyositis.. PubMed. 28(1). 207–11. 28 indexed citations
12.
Regan, Michael J. & Arthur Bienenstock. (1995). Characterization of phase separation in amorphous films using modern small-angle scattering methods. Journal of Non-Crystalline Solids. 192-193. 644–652. 5 indexed citations
13.
Regan, Michael J. & Arthur Bienenstock. (1995). Phase separation in sputtered amorphous metal-germanium alloys. Physical review. B, Condensed matter. 51(18). 12170–12186. 20 indexed citations
14.
Regan, Michael J. & Arthur Bienenstock. (1993). Anisotropic Phase Separation in Amorphous Fe-Ge Alloys. MRS Proceedings. 307. 1 indexed citations
15.
Regan, Michael J. & Edmond I. Eger. (1967). Effect of Hypothermia in Dogs on Anesthetizing and Apneic Doses of Inhalation Agents. Anesthesiology. 28(4). 689–700. 67 indexed citations
16.
Eger, Edmond I., et al.. (1966). Delayed Approach of Arterial to Alveolar Nitrous Oxide Partial Pressures in Dog and in Man . Anesthesiology. 27(3). 288–297. 12 indexed citations
17.
Munson, Edwin S., et al.. (1966). The Effects of Halothane, Fluroxene and Cyclopropane on Ventilation. Anesthesiology. 27(6). 716–728. 52 indexed citations
18.
Regan, Michael J. & Edmond I. Eger. (1966). Ventilatory Responses to Hypercapnia and Hypoxia at Normothermia and Moderate Hypothermia During Constant-Depth Halothane Anesthesia. Anesthesiology. 27(5). 624–633. 18 indexed citations
19.
Munson, Edwin S., et al.. (1966). The Effects of Halothane, Fluroxene, and Cyclopropane on Ventilation: A Comparative Study in Man. Anesthesiology. 27(2). 222–223. 1 indexed citations
20.
Eger, Edmond I., Bernard Brandstater, Lawrence J. Saidman, et al.. (1965). Equipotent Alveolar Concentrations of Methoxyflurane, Halothane, Diethyl Ether, Fluroxene, Cyclopropane, Xenon and Nitrous Oxide in the Dog. Anesthesiology. 26(6). 771–777. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026